Aoxin Q & M Dental Group Limited Announces Completion of Rights Issue: Key Details for Investors
Date of Announcement: 11 December 2025
Company: Aoxin Q & M Dental Group Limited
Event: Completion of Renounceable Non-Underwritten Rights Issue and Allotment of Rights Shares
Key Highlights
- Successful Rights Issue: Aoxin Q & M Dental Group Limited has completed its renounceable non-underwritten rights issue. A total of 511,522,048 Rights Shares have been allotted and issued to successful subscribers.
- Doubling of Share Capital: The company’s share capital has effectively doubled, increasing from 511,522,048 Shares to 1,023,044,096 Shares (excluding treasury shares and subsidiary holdings) as of the announcement date.
- Listing and Trading Details: The newly issued Rights Shares are expected to be listed and quoted on the Catalist of the Singapore Exchange Securities Trading Limited (SGX-ST) on 15 December 2025. Trading is expected to commence at 9:00 a.m. on the same day.
- Parity of Rights Shares: The Rights Shares, upon allotment and issuance, will rank pari passu in all respects with the existing Shares, except that they will not be entitled to any dividends, rights, allotments, or other distributions declared where the record date falls before the date of allotment and issue.
Important Information for Shareholders
- Trading of Odd Lots: Each board lot on the Catalist comprises 100 Shares. Shareholders holding odd lots (i.e., not in multiples of 100 Shares) can trade them on the SGX-ST’s Unit Share Market, which allows transactions of as few as one share. However, the market for odd lots may be illiquid, and there is no assurance that shareholders will be able to either round up to a full board lot or dispose of odd lots efficiently.
- Potential Impact on Share Price: The substantial increase in the number of shares (a 100% increase) could have a material impact on the share price due to dilution effects. Investors should closely monitor market reactions following the listing of the new Rights Shares.
- Ranking of New Shares: Investors should note that the new Rights Shares will not be eligible for any dividends, rights, or distributions declared before the allotment date. This is important for those seeking near-term yield or entitlements.
Other Noteworthy Information
- The announcement and its contents have been reviewed by the Company’s sponsor, PrimePartners Corporate Finance Pte. Ltd., but have not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of the announcement.
Summary for Investors
The completion of Aoxin Q & M Dental Group Limited’s rights issue and the upcoming listing of a significant number of new shares represent a major corporate event that could affect share price volatility and liquidity. Shareholders and investors should pay close attention to the trading debut of the new Rights Shares and assess the potential dilution impact alongside the company’s long-term growth prospects.
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors are advised to conduct their own due diligence and consult their financial advisers before making investment decisions. The information in this article is based on company announcements and may be subject to change.
